Company / R&D per Share
Maze Therapeutics, Inc. R&D per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$44.32
FY2025
5-year range
$44.32 / $44.32
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#5 of 208
Health Care
What the data says
Among 208 Health Care companies, Maze Therapeutics, Inc. is in the top 2% for r&d per share.
Based on SEC 10-K filings.
44.32 in FY2025. Top quartile in the Health Care sector.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 208This company $44.32 Sector average $28.82
▼
+53.8% above sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.32 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026